Evidence map›Paper›PMID 38193698›Full record

ArticlemBio2024

Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Competence Regulation inCurrent medicinal chemistry · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Tina H Dao *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Haley Echlin *Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0009-0009-4320-5595
Abigail McKnightDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Enolia S MarrDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Julia JunkerNationales Referenzzentrum für Streptokokken Abteilung Medizinische Mikrobiologie, Universitätsklinikum RWTH Aachen, Aachen, Germany.
Qidong JiaDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Randall HaydenDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-3073-4115
Tim van OpijnenBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Ralph R IsbergDeptartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-8330-3554
Vaughn S CooperCenter for Evolutionary Biology and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7726-0765
Jason W RoschDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-1798-1760
St. Jude Children's Research Hospital · USBroad Institute · USTufts University · USUniversitätsklinikum Aachen · DEUniversity of Pittsburgh · US

Funding

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
Drug resistance enablers and their role in antibiotic treatment failureU19AI158076 · NIAID · BROAD INSTITUTE, INC. · PI VAN OPIJNEN, TIM · 2022 to 2025
$10.0M
Evolvable essentiality in the pan-genome of Streptococcus pneumoniae and its mechanistic and evolutionary consequencesR01AI171038 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Jason W. Rosch, Federico Antonio Rosconi · 2022 to 2026
$3.0M
Consequences of Direct Viral-Bacterial InteractionsR56AI155614 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ORTIZ-MARQUEZ, JUAN CESAR FEDERICO, ROSCH, JASON W. · 2021 to 2021
$531k
NIAID NIH HHS R01 AI171038NIAID NIH HHS R56 AI155614NIAID NIH HHS U01 AI124302NIAID NIH HHS U19 AI158076
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FluoroquinolonesPneumococcal InfectionsAnimalsAnti-Bacterial AgentsDrug Resistance, BacterialHumansMammalsMiceMicrobial Sensitivity TestsStreptococcus pneumoniaeAnti-Bacterial AgentsFluoroquinolonesantibiotic resistanceStreptococcus pneumoniaevirulence

Identifiers

PMID38193698
PMCPMC10865975
OpenAlexW4390776135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.